'It is very hard to produce a timely book about a subject that changes as quickly as technologically assisted reproduction, but John Harris and Soren Holm have managed to do exactly that. The fourteen essays in this small volume provide an extremely useful and highly readable overview of the key moral, legal, and social themes raised by new ways of making babies. . . . The book is unique in that it offers perspectives on all these topics from a variety of disciplines and professions as well as from a broad range of national and cultural perspectives.' Arthur Caplan, British Medical Journal

In China, as elsewhere, the debate over genetically modified organisms has become polarized into anti- and pro-GMO camps. Given the size of China's population and market, much is at stake in conflicts over regulation for domestic as well as international actors. In this book, Cong Cao provides an even-handed analysis that illuminates the tensions that have shaped China's policy toward agricultural biotechnology in a global perspective. Cao presents a comprehensive and systematic analysis of how China's policy toward research and commercialization of genetically modified crops has shifted that explains how China's changing GMO stances reflect its evolving position on the world stage. While China's scientific community has set the agenda, it has encountered resistance rooted in concerns over food safety and consumers' rights as well as issues of intellectual property rights and food sovereignty. Although Chinese leaders at first sought to take advantage of the biotech revolution by promoting GMO crop consumption, Cao demonstrates that policy has since become precautionary, as seen in new laws and regulations grounded in concerns over safety and the deferral of commercialization of GM rice. He presents China's policies in light of changing global attitudes toward GM crops: As shifts in China have closely followed global trends, so has domestic activism. Drawing on government and scientific documents as well as interviews with scientists, officials, policy analysts, activists, and journalists, GMO China is an important book for China studies, science and technology studies, policy analysts, and professionals interested in the Chinese biotechnology market.

In 2001 the Human Genome Project succeeded in mapping the DNA of humans. This landmark accomplishment launched the field of genomics, the integrated study of all the genes in the human body and the related biomedical interventions that can be tailored to benefit a person's health. Today genomics, part of a larger movement toward personalized medicine, is poised to revolutionize health care. By cross-referencing an individual's genetic sequence - their genome - against known elements of "Big Data," elements of genomics are already being incorporated on a widespread basis, including prenatal disease screening and targeted cancer treatments. With more innovations soon to arrive at the bedside, the promise of the genomics revolution is limitless. This entry in the What Everyone Needs to Know series offers an authoritative resource on the prospects and realities of genomics and personalized medicine. As this science continues to alter traditional medical paradigms, consumers are faced with additional options and more complicated decisions regarding their health care. This book provides the essential information everyone needs.

Discovered little more than a decade ago, optogenetics - a revolutionary technique combining genetic and optical methods to observe and control the function of neurons - is now a widely used research tool. Optogenetics-driven research has led to insights into Parkinson's disease and other neurological and psychiatric disorders. With contributions from leaders and innovators from both academia and industry, this volume explores the discovery and application of optogenetics, from the basic science to its potential clinical use. Chapters cover a range of optogenetics applications, including for brain circuits, plasticity, memory, learning, sleep, vision and neurodegenerative and neuropsychiatric diseases. Providing authoritative coverage of the huge potential that optogenetics research carries, this is an ideal resource for researchers and graduate students, as well as for those working in the biotechnology and pharmaceutical industries and in a clinical setting.

The increasing integration between gene manipulation and genomics is embraced in this new book, Principles of Gene Manipulation and Genomics, which brings together for the first time the subjects covered by the best-selling books Principles of Gene Manipulation and Principles of Genome Analysis & Genomics. * Comprehensively revised, updated and rewritten to encompass within one volume, basic and advanced gene manipulation techniques, genome analysis, genomics, transcriptomics, proteomics and metabolomics * Includes two new chapters on the applications of genomics * An accompanying website - www.blackwellpublishing.com/primrose - provides instructional materials for both student and lecturer use, including multiple choice questions, related websites, and all the artwork in a downloadable format. * An essential reference for upper level undergraduate and graduate students of genetics, genomics, molecular biology and recombinant DNA technology. An Instructor manual CD-ROM for this title is available. Please contact our Higher Education team at [email protected] for more information.

The ability to successfully clone genes underlies the majority of our knowledge in molecular and cellular biology. Gene Cloning introduces the diverse array of techniques available to clone genes and how they can be used effectively both in the research laboratory, to gain knowledge about the gene, and for use in biotechnology, medicine, the pharmaceutical industry, and agriculture. It shows how cloning genes is an integral part of genomics and underlines its relevance in the post-genomic age, as a tool required to test predictions of gene regulation and function made through bioinformatics. Applications of gene cloning in medicine, both for diagnosis and treatment, and in the pharmaceutical industry and agriculture, are also covered in the book.

Gene Cloning takes a fresh approach to teaching molecular and cellular biology and will be a valuable resource to both undergraduates and lecturers of biological and biomedical science courses.

Volume One discusses the problems inherent in allocating limited biomedical technologies: whose needs take precedence, what individual rights and responsibilities are involved, and when societal good justifies restricting individual good. Volume Two focuses on two substantive areas of biomedical policy beset by conflicts. Physicians, patients, and public officials are locked in new battles over whether and when life-extending technologies should be used or withdrawn. Meanwhile, researchers, government officials, and patients struggle to determine who will receive experimental medical treatment, and what procedures should be instituted to protect the recipients.

'This co-authored book explores how advances in cell biology, CRISPR gene editing and bioengineering might be used to make a live dragon. The result is a gloriously tongue-in-check scientific epic ... How to Build a Dragon or Die Trying is deliberately flamboyant and outrageous. ItaEURO (TM)s also funny and smart. Far from a how-to guide for neaEURO (TM)er-do-wells to weaponize reptiles, it is designed to spark healthy curiosity in anyone who enjoys a ripping good science read.'NatureWhat if you could have your own real dragon? While that might seem like just a fantasy, today cutting-edge science has brought us to the point where it might really be possible. This book looks into the possibilities of making living, fire-breathing dragons. The world has been fascinated with dragons for thousands of years. Fictional dragons still have a firm place in pop culture, such as Smaug from The Hobbit as well as the dragons in Game of Thrones and in the How to Train Your Dragon movies. This new book discusses using powerful technologies such as CRISPR gene editing, stem cells, and bioengineering to make real dragons. It also goes through what useful information we can learn from animals such as Pteranodons and amazing present-day creatures in our quest to build actual dragons. The book goes on to discuss the possibility of building other mythical creatures such as unicorns and mermaids. Overall, How to Build A Dragon is also meant as a satirical look at cutting-edge science, and it pokes fun at science hype. Anyone who is interested in dragons or cutting-edge science will enjoy this book! It is written in a humorous, approachable way making science fun and easy to understand, including for young adults.The author is well-known scientist Paul Knoepfler who is familiar to the public for his science, his blog The Niche, and his frequent contributions to lay stories on new science concepts such as stem cells and CRISPR. He also is known for his TED talk on designer babies with more than 1.3 million views, and his two books - . The co-author, his daughter Julie Knoepfler, is a high school student interested in science and writing. She has her own blog on literary and film analysis, and enjoys taking a humorous look at culture through writing.

The long-awaited revision of the industry standard on phylogenetics

Since the publication of the first edition of this landmark volume more than twenty-five years ago, phylogenetic systematics has taken its place as the dominant paradigm of systematic biology. It has profoundly influenced the way scientists study evolution, and has seen many theoretical and technical advances as the field has continued to grow. It goes almost without saying that the next twenty-five years of phylogenetic research will prove as fascinating as the first, with many exciting developments yet to come.

This new edition of "Phylogenetics" captures the very essence of this rapidly evolving discipline. Written for the practicing systematist and phylogeneticist, it addresses both the philosophical and technical issues of the field, as well as surveys general practices in taxonomy. Major sections of the book deal with the nature of species and higher taxa, homology and characters, trees and tree graphs, and biogeography--the purpose being to develop biologically relevant species, character, tree, and biogeographic concepts that can be applied fruitfully to phylogenetics.

The book then turns its focus to phylogenetic trees, including an in-depth guide to tree-building algorithms. Additional coverage includes:

Parsimony and parsimony analysis

Parametric phylogenetics including maximum likelihood and Bayesian approaches

Phylogenetic classification

Critiques of evolutionary taxonomy, phenetics, and transformed cladistics

Specimen selection, field collecting, and curating

Systematic publication and the rules of nomenclature

Providing a thorough synthesis of the field, this important update to "Phylogenetics" is essential for students and researchers in the areas of evolutionary biology, molecular evolution, genetics and evolutionary genetics, paleontology, physical anthropology, and zoology.

In "Enhancing Evolution," leading bioethicist John Harris dismantles objections to genetic engineering, stem-cell research, designer babies, and cloning and makes an ethical case for biotechnology that is both forthright and rigorous. Human enhancement, Harris argues, is a good thing--good morally, good for individuals, good as social policy, and good for a genetic heritage that needs serious improvement. "Enhancing Evolution" defends biotechnological interventions that could allow us to live longer, healthier, and even happier lives by, for example, providing us with immunity from cancer and HIV/AIDS. Further, Harris champions the possibility of influencing the very course of evolution to give us increased mental and physical powers--from reasoning, concentration, and memory to strength, stamina, and reaction speed. Indeed, he says, it's not only morally defensible to enhance ourselves; in some cases, it's morally obligatory.

In a new preface, Harris offers a glimpse at the new science and technology to come, equipping readers with the knowledge to assess the ethics and policy dimensions of future forms of human enhancement.

Analysis of the equine genome began just over a decade ago, culminating in the recent complete sequencing of the horse genome. The availability of the equine whole genome sequence represents the successful completion of an important era of equine genome analysis, and the beginning of a new era where the sequence information will catalyze the development of new tools and resources that will permit study of a range of traits that are economically important and are significant to equine health and welfare."Equine Genomics" provides a timely comprehensive overview of equine genomic research. Chapters detail key accomplishments and the current state of research, as well as looking forward to possible applications of genomic technologies to horse breeding, health, and welfare. "Equine Genomics" delivers a global overview of the topic and is seamlessly edited by a leading equine genomics researcher. "Equine Genomics" is an indispensible source of information for anyone with an interest in this increasingly important field of study, including equine genomic researchers, clinicians, animal science professionals and equine field veterinarians.

Continued advances in biotechnology have driven forward the harnessing of micro-organisms and plants to help protect our fragile environment from the impact of human activity in increasingly targeted yet diverse ways. Environmental Biotechnology provides a broad overview of the subject, focusing on how biotechnological techniques are applied to solve environmental problems, rather than giving detailed explanations of the techniques themselves. Opening with an overview of environmental biotechnology, and a review of the key aspects of microbiology upon which the field is based, the book goes on to explore the diverse way in which biotechnology is applied to tackle environmental problems and issues, from monitoring of the environment and treatment of waste, to the removal of pollutants and extraction of oil and minerals. The book closes with a discussion of the ways in which future advances in biotechnology are likely to be harnessed to address current and emerging issues and problems in increasingly effective and powerful ways. Capturing the current excitement in a field reinvigorated by advances in genetic manipulation, and emerging genomic and proteomic technologies, Environmental Biotechnology is the perfect resource for any student needing to develop a sound understanding of biotechnology, and the diverse ways it can be applied to address important environmental issues. Online Resource Centre - Figures from the book available to download, to facilitate lecture preparation - Library of web links cited in the book, to give students ready access to these additional resources

In 2001 the Human Genome Project succeeded in mapping the DNA of humans. This landmark accomplishment launched the field of genomics, the integrated study of all the genes in the human body and the related biomedical interventions that can be tailored to benefit a person's health. Today genomics, part of a larger movement toward personalized medicine, is poised to revolutionize health care. By cross-referencing an individual's genetic sequence - their genome - against known elements of "Big Data," elements of genomics are already being incorporated on a widespread basis, including prenatal disease screening and targeted cancer treatments. With more innovations soon to arrive at the bedside, the promise of the genomics revolution is limitless. This entry in the What Everyone Needs to Know series offers an authoritative resource on the prospects and realities of genomics and personalized medicine. As this science continues to alter traditional medical paradigms, consumers are faced with additional options and more complicated decisions regarding their health care. This book provides the essential information everyone needs.

The author of the international bestseller The Sixth Extinction returns to humanity's transformative impact on the environment, now asking: after doing so much damage, can we change nature, this time to save it? Meet the biologists trying to save the world's rarest fish; the engineers who are turning carbon emissions to stone; the researchers trying to develop a 'super coral'; and the physicists contemplating shooting tiny diamonds into the stratosphere to cool the earth. Elizabeth Kolbert is one of the most important writers on the environment. Here she investigates the immense challenges humanity faces as we scramble to reverse, in a matter of decades, the effects we've had on the natural world and asks - can we save the natural world in time? 'Important, necessary, urgent' Helen MacDonald 'Meticulously researched and deftly crafted' Guardian

DNA microarrays, or biochips, are small glass chips embedded with ordered rows of DNA and by providing a massive parallel platform for data gathering represent a fundamental technical advance in biomedical research. This volume is a comprehensive overview of DNA microarray technology and will be invaluable to any researcher interested in taking advantage of this powerful new technique.

Once confined to the research laboratory, the genetic engineering of plants is now a big business that is changing the face of modern agriculture. Giant corporations are creating designer crops with strange powers, from cholesterol-reducing soybeans to plants that act as miniature drug factories, churning out everything from vaccines to insulin. They promise great benefits: better health for consumers, more productive agriculture - even an end to world hunger. But the vision has a dark side, one of profit-driven tampering with life and the possible destruction of entire ecosystems. In this text Daniel Charles takes us deep inside research labs, farm sheds and corporate boardrooms to reveal the hidden story behind this agricultural revolution. He tells how a handful of scientists at Monsanto drove biotechnology from the lab into the field, and how the company's opponents are fighting back with every tool available to them, including the cynical manipulation of public fears. A dramatic account of boundless ambition, political intrigue and the quest for knowledge, this is ultimately a story of idealism and of conflicting dreams about the shape of a better world.

Mutant Ecologies traces the spinning of new synthetic threads into the web of life. It is a critical cartography of the shifting landscapes of capital accumulation conjured by recent developments in genomic science, genome editing and the biotech industry. CRISPR crops, fast-growing salmons, heat-resistant Slick (TM) cows, Friendly (TM) Mosquitoes, humanised mice, pigs growing human organs - these are but a few of the dazzling new life-forms that have recently emerged from corporate and university laboratories around the world, all promising to lubricate the circuits of capital accumulation in distinct ways. The deliberate induction of genetic mutations is increasingly central to business operations in a number of sectors, from agriculture to pharmaceuticals. While the Nobel Committee recently proclaimed the life sciences to have entered 'a new epoch', the authors show how these technological innovations continue to operate within a socio-historical context defined by the iron rules of capitalist competition and exploitation. Capital no longer contents itself with simply appropriating the living bodies of plants and animals. It purposefully designs their internal metabolism, and in that way it redesigns the countless living vectors that constitute the global biosphere. It is driving a biological revolution, which will ripple through the everyday lives of people everywhere.

Jobst Conrad prasentiert die Ergebnisse einer sozialwissenschaftlichen Begleitstudie, die den Prozess und die Chancen der Umsetzung des InnoRegio-Programms des BMBF in der Praxis untersucht. Daruber hinaus gibt er einen Uberblick uber Innovations- und Netzwerkkonzepte, Innovationsdynamik und Technologiepolitik sowie uber Geschichte und Entwicklungstrends der Biotechnologie, Biotechnologiepolitik und Gentechnikdiskurs.

"Gene Therapy for Cartilage and Bone Tissue Engineering" outlines the tissue engineering and possible applications of gene therapy in the field of biomedical engineering as well as basic principles of gene therapy, vectors and gene delivery, specifically for cartilage and bone engineering. It is intended for tissue engineers, cell therapists, regenerative medicine scientists and engineers, gene therapist and virologists. Dr. Yu-Chen Hu is a Distinguished Professor at the Department of Chemical Engineering, National Tsing Hua University and has received the Outstanding Research Award (National Science Council), Asia Research Award (Society of Chemical Engineers, Japan) and Professor Tsai-Teh Lai Award (Taiwan Institute of Chemical Engineers). He is also a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a member of the Tissue Engineering International & Regenerative Medicine Society (TERMIS)-Asia Pacific Council.

Entwicklungen in Biomedizin, Genetik und Informatik fA1/4hren zu einem Wissenszuwachs im VerstAndnis der Ursachen und Entstehungsmechanismen von Krankheiten. Damit verbunden ist die Hoffnung, zukA1/4nftig Krankheitsrisiken frA1/4hzeitiger zu erkennen und durch MaAnahmen der Entwicklung von Krankheiten vorzubeugen. Mehr als andere Untersuchungsergebnisse erlauben genetische Informationen Aussagen A1/4ber den Gesundheitszustand auch von FamilienangehArigen. Sie bergen damit das Risiko konfligierender Interessen im Hinblick auf deren autonome LebensfA1/4hrung und informationelle Selbstbestimmung in sich.

Das Buch enthAlt die auf dem 10. Einbecker Workshop gehaltenen VortrAge, die sich aus medizinisch-naturwissenschaftlicher und juristischer Sicht mit dem Thema befassen. Im Anhang werden wichtige Materialien zum Thema Gentest ergAnzt. So ist das Asterreichische Gentechnikgesetz, der Schweizer Entwurf eines Gentestgesetzes und der Entwurf der Fraktion der GRAoeNEN im Bundestag fA1/4r ein Deutsches Gentestgesetz enthalten.

Der Autor erklart die Widerstande gegen einzelne Anwendungsbereiche der Gentechnik, beleuchtet deren historische Hintergrunde und untersucht Moglichkeiten, die Akzeptanz der Gentechnik zu beeinflussen."

This book provides a timely overview of toxicogenomics, with special emphasis on the practical applications of this technology to the risk assessment process. Introductory sections are followed by a series of chapters highlighting practical and systematic applications of toxicogenomics in informing the risk assessment process - including the areas of mutagenicity, carcinogenicity, endocrine toxicity, organ-specific toxicity, population monitoring, and ecotoxicology. The book concludes with approaches for the integration of this technology in safety evaluation studies, and an outlook on how toxicogenomics and complementary technologies can reframe the current risk assessment paradigm.

Das vorliegende Buch entstand aus Vorlesungen fUr Studenten des Bergbaus, des Hiittenwesens und des Wirtschaftsingenieurwesens, die als Grundlage ihrer Berufs tatigkeit viele Gebiete des klassischen Maschinenbaus kennen miissen, und zwar sowohlKraft- und Arbeitsmaschinen und -anlagen als auch iibergreifende Gebiete, u. a. MeBtechnik und Steuerungs- und Regelungstechnik. Die Darstellung muBte also auf die Bediirfnisse von Anwendern abgestellt werden, die unterschiedliche Maschinen und Anlagen technisch richtig und wirtschaftlich giinstig einsetzen miissen. Urn diese Aufgaben meistern zu konnen, bedarf ein solcher Anwender der Zusammenarbeit mit Spezialisten, die diese Maschinen und Anlagen in allen Einzelheiten kennen. Diese Zusammenarbeit kann er aber nur dann fruchtbar und ohne Zeitverlust aufnehmen, wenn er die spezielle Sprache des Einzelgebietes versteht und vor allen Dingen sich in dessen spezielle Probleme gut hineinfinden kann. Hierzu bedarf es neben grundlegenden mathematisch-naturwissenschaftlichen und technischen Kenntnissen und Fahigkeiten des Einblickes in die Technik dieser Maschinen und Anlagen. Beim Erwerb dieses Einblickes solI das vorliegende Buch helfen. Dieser Einblick in zahlreiche Gebiete muBte in einer iibersehbaren Darstellung geboten werden. HierfUr wurde folgendes Konzept zugrunde gelegt: Die klassische Einteilung in Kraft- und Arbeitsmaschinen wurde beibehalten, urn dem Leser einen leichteren Einstieg auch in die spezielle Literatur zu ermoglichen. Urn bei den zahlreichen zu behandelnden Gebieten eine zusatzliche Systematisierung zu erreichen, wurde nicht nur nach Kraft- und Arbeitsmaschinen, sondern auch nach Maschinen und Anlagen unterschieden. Naheres hierzu findet sich in Abschnitt 1."

Bringing together the ideas of experts from around the world, this incisive text offers cutting-edge perspectives on the risk analysis and governance of genetically modified organisms (GMOs), supporting effective and informed decision-making in developing countries. Comprised of four comprehensive sections, this book covers: integrated risk analysis and decision making, giving an overview of the science involved and examining risk analysis methods that impact decision-making on the release of GMOs, particularly in developing countries; diversification of expertise involved in risk analysis and practical ways in which the lack of expertise in developing countries can be overcome; risk analysis based regulatory systems and how they can be undermined by power relationships and socio-political interests, as well as strategies for improving GMO policy development and regulatory decision-making; and case studies from developing countries providing lessons based on real-world experience that can inform our current thinking.

The first unequivocal success for Gene Therapy was reported in April 2000 for X-SCID patients. Pioneering stem cell/gene therapy clinical trials are the focus of this book. Therapy successes such as the X-SCID trial and improved ADA-SCID ones are presented together with pioneering angio/vasculogenic clinical trials mediated either by transient gene therapy or emerging autologous stem cell transplantation. Highlights also include 1) promises of the breakthrough combination of stem cell- and transient gene-therapy, 2) gene therapy trials for neurodegenerative disease on non-human primates where long-term gene therapy might involve brain stem cells, and 3) the first clinical trial with non-invasive monitoring of therapeutic gene expression as a prospective conclusion. This volume will be of value and interest to researchers in this exciting field.